Brief: GoodRx Announces Preliminary Q4 And Full Year 2023 Results

GoodRx Holdings

10/01/2024 14:07

Jan 10 (Reuters) - Goodrx Holdings Inc  GDRX.O :
    * GOODRX ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL YEAR
2023
RESULTS AND EARLY EXPECTATIONS FOR FIRST QUARTER AND FULL YEAR
2024
    * 2023 REVENUE EXPECTED TO BE IN RANGE OF $749 MILLION TO
$751
MILLION
    * SAYS Q4 REVENUE AND ADJUSTED REVENUE EXPECTED TO BE IN
RANGE OF
$195 MILLION TO $197 MILLION
    * CONFIDENT THAT Q1 AND FULL YEAR 2024 REVENUE AND ADJUSTED
REVENUE WILL GROW MID-SINGLE DIGIT PERCENTAGES YEAR-OVER-YEAR
    * CONFIDENT THAT Q1 AND FULL YEAR 2024 ADJUSTED EBITDA
MARGIN WILL
BE IN HIGH TWENTY-PERCENT RANGE FOR BOTH PERIODS
    * Q4 REVENUE VIEW $190.8 MILLION -- LSEG IBES DATA
    * FY2023 REVENUE VIEW $744.3 MILLION -- LSEG IBES DATA

Source text for Eikon:  ID:nBw1PhdGZa 
Further company coverage:  GDRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))